IL2 and systemic lupus erythematosus: Knocking down Set1 with siRNA in SLE CD4+ T cells resulted in reduced both Set1 binding and H3K4me3 enrichment at the CREMα promoter, thus suppressing the expression of CREMα, and increasing the amount of IL-2, simultaneously decreasing the production of IL-17A.